Skip to main content
. 2022 Sep 2;13:996348. doi: 10.3389/fimmu.2022.996348

Table 2.

Cells impairment and prognostic cells in aNSCLCs.

Tn/Tm Compared with the NCs Compared with the Stage Ⅲ PFS
All aNSCLCs Stage Ⅲ Stage Ⅳ Stage Ⅳ % AC
% AC % AC % AC % AC
CD4+ Tn
CD4+ Tscm
CD4+ Tcm
CD4+ Tem
CD4+ Tte
CD8+ Tn
CD8+ Tscm
CD8+ Tcm
CD8+ Tem
CD8+ Tte

%: percentage; ★: P< 0.05.